Financial Review: Advanced Credit Technologies (OTCMKTS:ACRT) vs. Enfusion (NYSE:ENFN)

Enfusion (NYSE:ENFNGet Free Report) and Advanced Credit Technologies (OTCMKTS:ACRTGet Free Report) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, profitability, earnings and institutional ownership.

Valuation & Earnings

This table compares Enfusion and Advanced Credit Technologies”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Enfusion $188.35 million 5.94 $6.03 million $0.03 291.00
Advanced Credit Technologies N/A N/A N/A N/A N/A

Enfusion has higher revenue and earnings than Advanced Credit Technologies.

Profitability

This table compares Enfusion and Advanced Credit Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Enfusion 1.98% 6.17% 4.51%
Advanced Credit Technologies N/A N/A N/A

Insider & Institutional Ownership

81.1% of Enfusion shares are held by institutional investors. 36.4% of Enfusion shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Enfusion and Advanced Credit Technologies, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Enfusion 3 2 1 0 1.67
Advanced Credit Technologies 0 0 0 0 N/A

Enfusion currently has a consensus target price of $9.33, indicating a potential upside of 6.91%. Given Enfusion’s higher possible upside, equities analysts clearly believe Enfusion is more favorable than Advanced Credit Technologies.

Summary

Enfusion beats Advanced Credit Technologies on 8 of the 8 factors compared between the two stocks.

About Enfusion

(Get Free Report)

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

About Advanced Credit Technologies

(Get Free Report)

Advanced Credit Technologies, Inc., a development-stage technology company, focuses on fraud prevention and credit management in the United States. The company provides CyberloQ, a banking fraud prevention technology that enables institutional clients to combat fraudulent transactions and unauthorized access to customer accounts; and Turnscor, a Web-based proprietary software platform, which allows its customers to monitor and manage their credit from the privacy of their own homes. Advanced Credit Technologies, Inc. was founded in 2008 and is based in Venice, Florida.

Receive News & Ratings for Enfusion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enfusion and related companies with MarketBeat.com's FREE daily email newsletter.